Literature DB >> 14662934

Epidemiology of Aspergillus terreus at a university hospital.

John W Baddley1, Peter G Pappas, Anita C Smith, Stephen A Moser.   

Abstract

Invasive fungal infections due to Aspergillus species have become a major cause of morbidity and mortality among immunocompromised patients. Aspergillus terreus, a less common pathogen, appears to be an emerging cause of infection at our institution, the University of Alabama hospital in Birmingham. We therefore investigated the epidemiology of A. terreus over the past 6 years by using culture data; antifungal susceptibility testing with amphotericin B, voriconazole, and itraconazole; and molecular typing with random amplification of polymorphic DNA-PCR (RAPD-PCR). During the study period, the percentage of A. terreus isolates relative to those of other Aspergillus species significantly increased, and A. terreus isolates frequently were resistant to amphotericin B. Molecular typing with the RAPD technique was useful in discriminating between patient isolates, which showed much strain diversity. Further surveillance of A. terreus may better define epidemiology and determine whether this organism is becoming more frequent in relation to other Aspergillus species.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14662934      PMCID: PMC308992          DOI: 10.1128/JCM.41.12.5525-5529.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  Molecular typing of Aspergillus terreus by random amplification of polymorphic DNA.

Authors:  M Birch; D W Denning
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-11       Impact factor: 3.267

2.  Aspergillus terreus infections in haematological malignancies: molecular epidemiology suggests association with in-hospital plants.

Authors:  C Lass-Flörl; P Rath; D Niederwieser; G Kofler; R Würzner; A Krezy; M P Dierich
Journal:  J Hosp Infect       Date:  2000-09       Impact factor: 3.926

3.  Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America.

Authors:  D A Stevens; V L Kan; M A Judson; V A Morrison; S Dummer; D W Denning; J E Bennett; T J Walsh; T F Patterson; G A Pankey
Journal:  Clin Infect Dis       Date:  2000-04-20       Impact factor: 9.079

4.  Molecular typing of Aspergillus terreus isolates by random amplification of polymorphic DNA.

Authors:  F Symoens; J P Bouchara; S Heinemann; N Nolard
Journal:  J Hosp Infect       Date:  2000-04       Impact factor: 3.926

Review 5.  Invasive pulmonary aspergillosis due to Aspergillus terreus: 12-year experience and review of the literature.

Authors:  P C Iwen; M E Rupp; A N Langnas; E C Reed; S H Hinrichs
Journal:  Clin Infect Dis       Date:  1998-05       Impact factor: 9.079

6.  In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole.

Authors:  D A Sutton; S E Sanche; S G Revankar; A W Fothergill; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

7.  Molecular typing by random amplification of polymorphic DNA and M13 southern hybridization of related paired isolates of Aspergillus fumigatus.

Authors:  M J Anderson; K Gull; D W Denning
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

8.  Molecular epidemiology of apparent outbreak of invasive aspergillosis in a hematology ward.

Authors:  A Leenders; A van Belkum; S Janssen; S de Marie; J Kluytmans; J Wielenga; B Löwenberg; H Verbrugh
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

Review 9.  Fatal disseminated infection with Aspergillus terreus in immunocompromised hosts.

Authors:  D M Tritz; G L Woods
Journal:  Clin Infect Dis       Date:  1993-01       Impact factor: 9.079

10.  Use of randomly amplified polymorphic DNA markers to distinguish isolates of Aspergillus fumigatus.

Authors:  A Aufauvre-Brown; J Cohen; D W Holden
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

View more
  34 in total

1.  Aspergillus terreus infection in a sutureless self-sealing incision made during cataract surgery.

Authors:  Elif Erdem; Hazal Kandemir; Sevtap Arıkan-Akdağlı; Ebru Esen; Arbil Açıkalın; Meltem Yağmur; Macit İlkit
Journal:  Mycopathologia       Date:  2014-11-02       Impact factor: 2.574

2.  Extracellular proteome of Aspergillus terreus grown on different carbon sources.

Authors:  Mee-Jung Han; Nag-Jong Kim; Sang Yup Lee; Ho Nam Chang
Journal:  Curr Genet       Date:  2010-06-08       Impact factor: 3.886

Review 3.  In vitro analyses, animal models, and 60 clinical cases of invasive Aspergillus terreus infection.

Authors:  William J Steinbach; John R Perfect; Wiley A Schell; Thomas J Walsh; Daniel K Benjamin
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

Review 4.  Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus.

Authors:  M A Pfaller; D J Diekema
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

Review 5.  Epidemiology of invasive candidiasis: a persistent public health problem.

Authors:  M A Pfaller; D J Diekema
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

6.  Monoclonal antibodies to hyphal exoantigens derived from the opportunistic pathogen Aspergillus terreus.

Authors:  Ajay P Nayak; Brett J Green; Erika Janotka; Justin M Hettick; Sherri Friend; Steve J Vesper; Detlef Schmechel; Donald H Beezhold
Journal:  Clin Vaccine Immunol       Date:  2011-07-06

7.  Environmental investigations and molecular typing of Aspergillus in a Chinese hospital.

Authors:  Jun-hong Ao; Zhen-feng Hao; He Zhu; Liang Wen; Rong-ya Yang
Journal:  Mycopathologia       Date:  2014-01-18       Impact factor: 2.574

8.  In vitro activities of amphotericin B, terbinafine, and azole drugs against clinical and environmental isolates of Aspergillus terreus sensu stricto.

Authors:  Mariana S Fernández; Florencia D Rojas; María E Cattana; María de Los Ángeles Sosa; Cristina A Iovannitti; Cornelia Lass-Flörl; Gustavo E Giusiano
Journal:  Antimicrob Agents Chemother       Date:  2015-03-30       Impact factor: 5.191

9.  Species Identification and In Vitro Antifungal Susceptibility of Aspergillus terreus Species Complex Clinical Isolates from a French Multicenter Study.

Authors:  E Dannaoui; F Botterel; S Imbert; A C Normand; S Ranque; J M Costa; J Guitard; I Accoceberry; C Bonnal; A Fekkar; N Bourgeois; S Houzé; C Hennequin; R Piarroux
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

10.  Rapid differentiation of Aspergillus species from other medically important opportunistic molds and yeasts by PCR-enzyme immunoassay.

Authors:  Liliana de Aguirre; Steven F Hurst; Jong Soo Choi; Jong Hee Shin; Hans Peter Hinrikson; Christine J Morrison
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.